UKONS 2017 | Patient care must be considered when using new anticancer drugs

Verna Lavender

As novel anticancer drugs undergo clinical trials and enter the market, patients with cancer are experiencing better outcomes and living longer. However, as outlined in this interview with Verna Lavender, PhD, of Oxford Brookes University, Oxford, UK, patients may develop more complex conditions and comorbidities as they get older, meaning that new drugs may not be suitable until more information is known. This interview was recorded at the UK Oncology Nursing Society (UKON) Annual Conference 2017, held in Harrogate, UK.

Share this video